Journal
ONCOLOGY LETTERS
Volume 20, Issue 3, Pages 2606-2612Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2020.11807
Keywords
osteosarcoma; long non-coding RNA; microRNA; chemotherapy resistance; biomarkers
Categories
Funding
- Chinese Medicine Administration Research Project of Gansu province [GZK-2019-46]
Ask authors/readers for more resources
Osteosarcoma is a malignant tumor that occurs in children and adolescents. Although treatments for osteosarcoma have improved, the likelihood of survival remains low for most patients with metastasis and recurrence. Elucidating the mechanism underlying the development of osteosarcoma and chemotherapy resistance will be important to improve diagnosis and treatment. Long non-coding RNAs (lncRNAs), which are longer than 200 nucleotides in length and do not encode for proteins, have been shown to play a regulatory role in the occurrence and development of osteosarcoma, and are expected to serve as biomarkers and molecular targets. This review discusses the progress in the study of the role of lncRNAs in osteosarcoma, and highlights the recent developments in this field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available